Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.

PloS One
Yin ChenGuisen Zhang

Abstract

It is important to develop novel antipsychotics that can effectively treat schizophrenia with minor side-effects. The aim of our work is to develop novel antipsychotics that act on dopamine D(2) and D(3), serotonin 5-HT(1A) and 5-HT(2A) receptors with low affinity for the serotonin 5-HT(2C) and H(1) receptors, which can effectively cure positive symptoms, negative symptoms and cognitive impairment without the weight gain side-effect. A series of 2-substituted-5-thiopropylpiperazine (piperidine) -1,3,4-oxadiazoles derivatives have been synthesized and the target compounds were evaluated for binding affinities to D(2), 5-HT(1A) and 5-HT(2A) receptors. Preliminary results indicated that compounds 14, 16 and 22 exhibited high affinities to D(2), 5-HT(1A) and 5-HT(2A) receptors among these compounds. Further binding tests showed that compound 22 had high affinity for D(3) receptor, and low affinity for serotonin 5-HT(2C) and H(1) receptors. In addition, compound 22 inhibited apomorphine-induced climbing behavior and MK-801-induced hyperactivity with no extrapyramidal symptoms liability in mice. Moreover, compound 22 exhibited acceptable pharmacokinetic properties. Compound 22 showed an atypical antipsychotic activity without liabili...Continue Reading

References

Apr 1, 1978·Psychoneuroendocrinology·A E Boyd, S Reichlin
Mar 1, 1991·Schizophrenia Research·S R MarderT Van Putten
Jun 1, 1991·Journal of Medicinal Chemistry·J A LoweJ S Furman
Mar 1, 1991·Pharmacopsychiatry·D Naber, H Hippius
Oct 1, 1988·Journal of Medicinal Chemistry·R A GlennonM Titeler
Jan 1, 1980·Annual Review of Neuroscience·R J Baldessarini, D Tarsy
Jan 1, 1983·Schizophrenia Bulletin·R R LewineH Y Meltzer
Apr 1, 1997·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·C A Tamminga
Aug 27, 1998·Neuroscience Letters·R T KhistiC T Chopde
Mar 12, 1999·British Journal of Clinical Pharmacology·M CampbellS H Thomas
Apr 3, 1999·British Journal of Pharmacology·C ReavillT P Blackburn
Dec 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·X XiberasM L Paillère-Martinot
Mar 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Wesley K KroezeBryan L Roth
May 13, 2003·Nature Medicine·Erwan BézardPierre Sokoloff
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David A ShapiroRichard Mailman
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJunji Ichikawa
Mar 17, 2004·Current Opinion in Pharmacology·Herbert Y Meltzer
Oct 12, 2004·CNS Spectrums·Herbert Y Meltzer
Mar 3, 2005·The American Journal of Psychiatry·Paul R BucklandMichael C O'Donovan
Jun 21, 2006·Journal of Psychopharmacology·Gavin P ReynoldsShona L Kirk
Nov 7, 2006·Bioorganic & Medicinal Chemistry Letters·Vincenzo GarzyaEmiliangelo A Ratti
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sangwon F KimSolomon H Snyder
Dec 20, 2007·International Review of Psychiatry·A R YungP D Mcgorry
Jul 16, 2008·Neuropharmacology·Caitlin A Jones, Andrew C McCreary
Feb 10, 2009·Current Pharmaceutical Design·Richard Morphy, Zoran Rankovic
Mar 10, 2009·European Journal of Medicinal Chemistry·Mohamed Abdel-AzizAlaa A Hassan
Jan 1, 1995·European Psychiatry : the Journal of the Association of European Psychiatrists·H Meltzer, H Hippius
Dec 4, 2009·European Journal of Medicinal Chemistry·Francesco FrecenteseGiuseppe Caliendo
Jun 4, 2010·Central Nervous System Agents in Medicinal Chemistry·Yukihiro Ohno
Jul 2, 2010·Science Translational Medicine·Marios PolitisPaola Piccini

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

SPSS ( Statistical Package for the Social Science )

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here